The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes.

@article{Buse2004TheEO,
  title={The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes.},
  author={John B Buse and Meng H. Tan and Melvin Prince and Pennifer Erickson},
  journal={Diabetes, obesity & metabolism},
  year={2004},
  volume={6 2},
  pages={133-56}
}
AIM Patients with type 2 diabetes often have dyslipidaemia, putting them at risk of cardiovascular disease, and are frequently treated with oral anti-hyperglycaemic medications (OAMs). This review compares the effects of OAMs on serum lipids [total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TGs) and free fatty acids (FFAs)] in patients with type 2 diabetes. METHODS medline was searched for entries indexed from… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 49 extracted citations

Factors That Influence Pancreatic Beta Cell Function and Insulin Resistance in Newly Diagnosed Type 2 Diabetes Patients: A Sub-Analysis of the MARCH Trial

Diabetes therapy : research, treatment and education of diabetes and related disorders • 2018
View 1 Excerpt

Pharmacotherapy of type 2 diabetes: An update.

Metabolism: clinical and experimental • 2018
View 1 Excerpt

Similar Papers

Loading similar papers…